Midnight News Update – Jun 22nd 2020 Hetero Drugs of Hyderabad has secured approval from the Indian pharma regulator for the manufacture and marketing of Remdesivir, belonging to Gilead Inc of the US. Hetero was one of the licensees in India to manufacture Remdesivir, apart from Cipla and Jubilant Life. It will be marketed